| Title | Anti-Cancer Agents in Medicinal Chemistry |
| Abbreviation | Anti-Cancer Agents Med. Chem. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Molecular Medicine (Q3); Pharmacology (Q3); Cancer Research (Q4) |
| h-index | 103 |
| Overall Rank/Ranking | 11841 |
| SCImago Journal Rank (SJR) | 0.428 |
| Impact Score | 2.77 |
| Publisher | Bentham Science Publishers B.V. |
| Country | United Arab Emirates |
| ISSN | 18715206, 18755992 |
| Best Quartile | Q3 |
| Coverage History | 2006-2022 |
Anti-Cancer Agents in Medicinal Chemistry is a journal covering the technologies/fields/categories related to Molecular Medicine (Q3); Pharmacology (Q3); Cancer Research (Q4). It is published by Bentham Science Publishers B.V.. The overall rank of Anti-Cancer Agents in Medicinal Chemistry is 11841. According to SCImago Journal Rank (SJR), this journal is ranked 0.428. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 103. The best quartile for this journal is Q3.
The ISSN of Anti-Cancer Agents in Medicinal Chemistry journal is 18715206, 18755992. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Anti-Cancer Agents in Medicinal Chemistry is cited by a total of 1755 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Anti-Cancer Agents in Medicinal Chemistry is 2.77, which is computed in 2023 as per its definition. Anti-Cancer Agents in Medicinal Chemistry IF is increased by a factor of 0.56 and approximate percentage change is 25.34% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Anti-Cancer Agents in Medicinal Chemistry is 2.77. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.77 |
| 2021 | 2.21 |
| 2020 | 2.27 |
| 2019 | 1.96 |
| 2018 | 1.92 |
| 2017 | 2.03 |
| 2016 | 2.42 |
| 2015 | 2.91 |
| 2014 | 2.65 |
Anti-Cancer Agents in Medicinal Chemistry has an h-index of 103. It means 103 articles of this journal have more than 103 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Anti-Cancer Agents in Medicinal Chemistry is 18715206, 18755992. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Anti-Cancer Agents in Medicinal Chemistry is 11841. According to SCImago Journal Rank (SJR), this journal is ranked 0.428. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.428 |
| 2021 | 0.403 |
| 2020 | 0.508 |
| 2019 | 0.543 |
| 2018 | 0.528 |
| 2017 | 0.674 |
| 2016 | 0.807 |
| 2015 | 0.978 |
| 2014 | 0.963 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 11841 |
| 2021 | 12000 |
| 2020 | 9941 |
| 2019 | 9114 |
| 2018 | 9079 |
| 2017 | 7018 |
| 2016 | 5789 |
| 2015 | 4571 |
| 2014 | 4567 |
Anti-Cancer Agents in Medicinal Chemistry is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Anti-Cancer Agents in Medicinal Chemistry is Anti-Cancer Agents Med. Chem.. This abbreviation ('Anti-Cancer Agents Med. Chem.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Molecular Medicine (Q3); Pharmacology (Q3); Cancer Research (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Anti-Cancer Agents in Medicinal Chemistry latest impact IF is 2.77. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.91 (2015) and 1.92 (2018), respectively, in the last 9 years. Moreover, its average IS is 2.35 in the previous 9 years.
The Anti-Cancer Agents in Medicinal Chemistry has an SJR (SCImago Journal Rank) of 0.428, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.978 in 2015 and the lowest being 0.403 in 2021. Furthermore, the average SJR of the Anti-Cancer Agents in Medicinal Chemistry over the previous 9-year period stands at 2.35.
The latest h-index of the Anti-Cancer Agents in Medicinal Chemistry is 103.
The Anti-Cancer Agents in Medicinal Chemistry is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.
The Anti-Cancer Agents in Medicinal Chemistry is currently ranked 11841 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 4567 in 2014 and its lowest position of 12000 in 2021.
The standard ISO4 abbreviation for the Anti-Cancer Agents in Medicinal Chemistry is Anti-Cancer Agents Med. Chem..
Anti-Cancer Agents in Medicinal Chemistry is classified as a journal that the Bentham Science Publishers B.V. publishes.
The Anti-Cancer Agents in Medicinal Chemistry encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Anti-Cancer Agents in Medicinal Chemistry is assigned the following International Standard Serial Numbers (ISSN): 18715206, 18755992.
The best quartile for the Anti-Cancer Agents in Medicinal Chemistry is Q3 (2022).
The Anti-Cancer Agents in Medicinal Chemistry coverage history can be summarized as follows: 2006-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Business: Theory and Practice | journal | 13414 | Vilnius Gediminas Technical University | 21 | 2.47 |
| Qualitative Research | journal | 2108 | SAGE Publications Ltd | 86 | 3.97 |
| Clinical Medicine and Research | journal | 16602 | Marshfield Clinic | 60 | 1.06 |
| Journal of Supply Chain Management | journal | 378 | Wiley-Blackwell | 104 | 12.58 |
| Archives of Phytopathology and Plant Protection | journal | 14852 | Taylor and Francis Ltd. | 29 | 1.14 |
| Abacus | journal | 8398 | Wiley-Blackwell Publishing Ltd | 49 | 2.52 |
| International Journal of Research and Method in Education | journal | 5180 | Taylor and Francis Ltd. | 34 | 2.49 |
| Journal of Sociolinguistics | journal | 5409 | Wiley-Blackwell Publishing Ltd | 61 | 1.96 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.77 |
| 2021 | 2.21 |
| 2020 | 2.27 |
| 2019 | 1.96 |
| 2018 | 1.92 |
| 2017 | 2.03 |
| 2016 | 2.42 |
| 2015 | 2.91 |
| 2014 | 2.65 |
